体外研究 (In Vitro) |
Isocryptotanshinone (ICTS) (0-5 μM,0-24 小时) 以浓度和时间依赖性方式抑制 A549 细胞中组成型 STAT3 和 p-STAT3 的表达。
Isocryptotanshinone (5 μM,12 小时) 降低 A549 细胞质中的 STAT3 和细胞核中的 p-STAT3。
Isocryptotanshinone (5 μM,0-4 小时) 以在 A549 细胞中以时间依赖性方式抑制 IL-6 (25 ng/mL) 刺激的 p-STAT3 表达,并在 4 小时后几乎完全消除 p-STAT3 的表达。
Isocryptotanshinone (0-10 μM,0-24 小时) 以时间依赖性方式减弱生存相关蛋白 (Bcl-2、Bcl-xL、survivin、Mcl-1) 的表达,并以浓度依赖性方式抑制上游调节因子 (EGFR 和 JAK2) 的表达。
Isocryptotanshinone (0-20 μM,0-24 小时) 以浓度依赖性方式显著抑制 A549 和 95D 肺癌细胞的增殖,并通过显著增加早期凋亡细胞比例、caspase 3/7 活性和裂解 PARP 的表达来诱导 A549 细胞凋亡。
Isocryptotanshinone (0-10 μM, 0-24 小时) 通过上调 LC3II 表达、促进自噬泡和自噬溶酶体的积累、抑制 AKT/mTOR 信号通路,诱导 A549 细胞发生促死亡自噬,此作用与 Cryptotanshinone (MS-R04261) 类似。
Isocryptotanshinone (0-20 μM, 24 小时) 可通过诱导 G1 期细胞周期阻滞并引发早期凋亡,抑制 MCF-7 细胞增殖 (IC50 = 12.5 μM) 和集落形成。
Isocryptotanshinone (2.5-10 μM, 0-24 小时) 可激活 MCF-7 细胞中的 MAPK 信号通路,表现为 JNK、ERK 和 p38 MAPK 发生时间和浓度依赖的磷酸化。
Isocryptotanshinone (0-40 μM,0-72 小时) 抑制胃癌细胞增殖,对 SGC-7901 细胞的 IC50 为 6.77 μM,对 MKN-45 细胞的 IC50 为 33.1 μM。
Isocryptotanshinone (0-40 μM,24 小时) 诱导胃癌细胞 (SGC-7901 和 MKN-45) G1/G0 期细胞周期阻滞和凋亡,该作用通过抑制 STAT3 信号通路并伴随下调细胞周期和凋亡相关蛋白 (Cyclin D1、E2F1、Mcl-1、Bcl-2 和 survivin) 介导。
Western Blot Analysis
| Cell Line: |
MCF-7 cells |
| Concentration: |
2.5, 5 and 10 μM |
| Incubation Time: |
0, 1, 3, 6, 12, and 24 h |
| Result: |
Induced phosphorylation of JNK (p-JNK), ERK (p-ERK), and p38 (p-p38) in MCF-7 cells without affecting total JNK, ERK, or p38, in a time- and concentration-dependent manner.
Increased the phosphorylation of JNK, ERK, and p38 at 10 μM.
|
Cell Viability Assay
| Cell Line: |
MCF-7, MDA-MB-231, HepG2, A549, and 95D cells |
| Concentration: |
0-40 μM |
| Incubation Time: |
24 h |
| Result: |
Significantly inhibited the proliferation of MCF-7, MDA-MB-231, HepG2, A549 and 95D cells in a concentration-dependent manner.
Exhibited approximately 20% and 60% cell viability rates for A549 and 95D cells at 10 μM, respectively.
|
Western Blot Analysis
| Cell Line: |
SGC-7901 and MKN-45 cells |
| Concentration: |
0,2.5, 5, 10, 20 and 40 μM |
| Incubation Time: |
24 h |
| Result: |
Significantly downregulated the phosphorylation of Rb at Ser-807/811, and the expression of Cyclin D1 and E2F1 at 20 or 40 μM in SGC-7901 cells.
Decreased the expression levels of Mcl-1, Bcl-2, and Survivin at 20 and 40 μM in SGC-7901 cells.
Induced the same changes of protein marker in MKN-45 cells.
Inhibited the phosphorylation of STAT3 at Tyr-705 in a dose-dependent manner and had weak effect on the total protein.
Increased the phosphorylation of Akt at Ser-473 and no significant effects were observed on the phosphorylation of Erk1/2 at Thr-202/Tyr-204.
Decreased the expression levels of Akt and Erk1/2 at a higher concentration.
Significantly suppressed the IL-6 (25 ng/ml)-induced phosphorylation of STAT3 in SGC-7901 cells.
Inhibited the increase of the expression of Cyclin D1, p-Rb, and Survivin in SGC-7901 cells.
Suppressed the restored proliferation and the expression of Cyclin D1, p-Rb, and Survivin that were enhanced by STAT3 overexpression.
|
Western Blot Analysis
| Cell Line: |
A549 cells |
| Concentration: |
0, 2, 5, 7 and 10 μM |
| Incubation Time: |
0, 2, 6, 12, and 24 h |
| Result: |
Reduced STAT3 and p-STAT3 levels in a dose-dependent manner.
Reduced p-STAT3 levels in a time-dependent manner.
Decreased Bcl-2, Bcl-xL, Mcl-1, and survivin levels in a time-dependent manner.
Reduced EGFR and JAK2 levels in a concentration-dependent manner.
|
Cell Proliferation Assay
| Cell Line: |
MCF-7 cells |
| Concentration: |
1.25, 2.5, 5, 10 and 20 μM |
| Incubation Time: |
24 h |
| Result: |
Resulted in a remarkable decrease in MCF-7 cell colony number.
Almost completely inhibited colony formation by MCF-7 cells at 20 μM.
|
Cell Proliferation Assay
| Cell Line: |
SGC-7901 and MKN-45 cells |
| Concentration: |
0, 2.5, 10, 20, and 40 μM |
| Incubation Time: |
0,24, 48, and 72 h |
| Result: |
Inhibited the proliferation of SGC-7901 cells in a dose-dependent manner.
Suppressed the proliferation of SGC-7901 cells at 10 μM in a time-dependent manner.
Inhibited MKN-45 cell growth in a dose- and time-dependent manner.
|
Apoptosis Analysis
| Cell Line: |
A549 cells |
| Concentration: |
0, 2, 5, 7 and 10 μM |
| Incubation Time: |
4 and12 h |
| Result: |
Remarkably increased early apoptotic cell fractions in a concentration-dependent manner in A549 cells.
Increased caspase 3/7 activities by approximately 53 times at 10 μM after 5 h in A549 cells.
Increased the expression of cleaved PARP in A549 cells.
|
Apoptosis Analysis
| Cell Line: |
MCF-7 cells |
| Concentration: |
2.5, 5, 10 and 20 μM |
| Incubation Time: |
0, 4, 8, 20 and 24 h |
| Result: |
Induced MCF-7 cells apoptosis, with nuclear condensation and fragmentation.
Resulted DNA diffuse fragmentation in MCF-7 cells.
Decreased antiapoptotic proteins Bcl-2 and Bcl-XL, and increased proapoptotic proteins BAX and BAK in MCF-7 cells.
Increased cleaved PARP, cleaved caspase-3, and caspase-9 levels in MCF-7 cells.
Decreased MMP levels in a time-dependent manner.
|
Cell Autophagy Assay
| Cell Line: |
A549 cells |
| Concentration: |
0, 2.5, 5 and 10 μM |
| Incubation Time: |
0, 1, 3, 6, 12 and 24 h |
| Result: |
Dramatically increased the expression of LC3II in a time-dependent manner.
Decreased the expression of p-AKT (Ser473), p-AKT (Thr308), and p-mTOR (Ser2448) without affecting p62.
Resulted in the accumulation of autophagic vacuoles and increased autolysosomes.
|
Cell Cycle Analysis
| Cell Line: |
MCF-7 cells |
| Concentration: |
2.5, 5 and 10 μM |
| Incubation Time: |
24 h |
| Result: |
Showed a significant increase in the proportion of G1 phase cells in comparison with the control group at 10 μM. |
Cell Cycle Analysis
| Cell Line: |
SGC-7901 and MKN-45 cells |
| Concentration: |
0, 2.5, 5, 10, 20 and 40 μM |
| Incubation Time: |
24 h |
| Result: |
Arrested SGC-7901 cells in the G1/G0 phase of the cell cycle in a dose-dependent manner.
Markedly increased the proportion of SGC-7901 cells in the G1/G0 phase from 47.9% to 65.7% at 10 μM.
Decreased proportion of cells in the S and G2/M phases at 10 μM.
Increased the SGC-7901 cell number in the sub-G1 phase significantly at 10 μM.
Induced cell cycle arrest in the G1/G0 phase in MKN-45 cells and increased cell proportion in the sub-G1 phase of cell cycle at higher concentration.
|
Apoptosis Analysis
| Cell Line: |
SGC-7901 and MKN-45 cells |
| Concentration: |
0, 2.5, 5, 10, 20 and 40 μM |
| Incubation Time: |
24 h |
| Result: |
Significantly increased SGC-7901 apoptosis percentage from 3.8% to 44.2% in a concentration-dependent manner.
showed apoptosis-inducing effects even at 2.5 and 5 μM.
Remarkably increased apoptotic cell number at higher concentration (40 μM).
Significantly upregulated the expression of cleaved caspase-9 and PARP in MKN-45 and SGC-7901 cells.
Promoted MKN-45 cell apoptosis in a dose-dependent manner.
|
|